Abstract: Objective To explore the effect of the clinical path management in treatment of vocal cord polyp and chronic tonsillitis,to provide the scientific advice for the standardization, regulation and homogeneity of the ear-nose-throat (ENT)single disease treatment.Methods A retrospective cohort study from Suining Center Hospital was applied to compare the status between traditional group and the clinical pathway group.The main evaluation indicators included hospital cost,hospitalization day and treatment effects.Results The differences of basic situation such as vocal cord polyp and chronic tonsillitis between the clinical pathway group and the control group were not significant (P>0.05).The average total cost of hospitalization,inspection fee, surgery fee,drugs fee,other treatment charge and the average hospitalization day of the vocal cord polyp clinical pathway group were less than those of the control group (P<0.05);the average total cost of hospitalization,inspection fee,surgery fee,drugs fee,nursing fee,other treatment charge and the average hospitalization day of the chronic tonsillitis clinical pathway group were less than those of the control group (P<0.01);Clinical curative effect between the vocal cord polyp clinical pathway group and the control group were not significant (P>0.05 );Clinical curative effect of chronic tonsillitis patients path group was higher (P<0.05 ),whereas the incidence of hospital complications,infection,between the path and control group were no significant (P>0.05).Conclusion Clinical path management can shorten the average length of hospitalization,reduce the hospital cost and improve the quality of diagnosis and treatment to help standardize the treatment of ENT diseases.

Key words: vocal cord polyp, chronic tonsillitis, clinical pathway, evaluation